ArticleOncotarget2017

Eugenol alleviated breast precancerous lesions through HER2/PI3K-AKT pathway-induced cell apoptosis and S-phase arrest.

Min Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.